Inventor
SIEGEL MARVIN I
US17 patents
⚠️ This page may combine multiple inventors who share the name “SIEGEL MARVIN I”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
15 patentsUS5116840AMay 26, 1992
Polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives
SCHERING CORP45 citations94
US5037826AAug 6, 1991
1-substituted naphthyridine and pyridopyrazine derivatives
SCHERING CORP36 citations92
US5439916AAug 8, 1995
Polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives
SCHERING CORP19 citations81
US5126352AJun 30, 1992
Polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives
SCHERING CORP19 citations81
US4564626AJan 14, 1986
Methods of inducing bronchodilation
SCHERING CORP23 citations81
US4988705AJan 29, 1991
Polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives
SCHERING CORP6 citations72
US4882332ANov 21, 1989
Immune suppression method employing arly-substituted naphthyridine and pyridopyrazine derivatives
SCHERING CORP5 citations62
US4801589AJan 31, 1989
Method for suppressing the immune response
SCHERING CORP6 citations62
US4775686AOct 4, 1988
Naphthyridine derivatives and method for treating allergic reactions
SCHERING CORP4 citations62
US4725596AFeb 16, 1988
Pyrimidine derivatives having anti-allergy, anti-inflammatory and immuno suppressant activity
SCHERING CORP3 citations62
US4687774AAug 18, 1987
Method for suppressing the immune response
SCHERING CORP4 citations62
US4666922AMay 19, 1987
Method for modulating the immune response
SCHERING CORP5 citations62
US4810708AMar 7, 1989
Polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives
SCHERING CORP4 citations61
US4916131AApr 10, 1990
Naphthyridine derivatives and method for treating allergic reactions
SCHERING CORP1 citations52
US5045542ASep 3, 1991
Immune suppression method employing aryl-substituted naphthyridine and pyridopyrazine derivatives
SCHERING CORP0 citations41